{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:49:28Z","timestamp":1769032168130,"version":"3.49.0"},"reference-count":19,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2019-0017_s_01\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To analyze the cardio-protective effects of ticagrelor in patients with acute coronary syndrome with S-T segment elevation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2019-0017_s_02\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The sample was 200 patients who had been diagnosed with acute coronary syndrome accompanied by diabetes Mellitus type II. Only patients having ST segment elevation before the treatment were included. Then, the subjects were further randomly divided into an observation group and a control group. The control group of 100 patients received clopidogrel; the observation group of 100 patients of ticagrelor. The serous creatine kinase CK-MB, functional cardiac indexes of left ventricular end diastolic diameter (LVDD), cardiac troponin I, ventricular ejection fraction, and relevant major adverse cardiovascular events (MACE) were compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2019-0017_s_03\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One month after a percutaneous coronary intervention (PCI) the observation group showed better results against angina, stent thrombosis, and all-cause mortality compared with those of the control subjects. Six months after treatment, both groups suffered adverse reactions. The number of patients who suffered adverse reactions in respiratory tract in the observation group was higher than in the control group. The inhibition of platelet aggregation IPA of ticagrelor was found to be significantly higher than clopidogrel, having a significant p value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2019-0017_s_04\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ticagrelor can effectively protect myocardial function for patients with ST-segment elevation acute coronary syndrome accompanied by diabetes and can reduce the incidence of adverse reactions..<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2019-0017","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T04:02:01Z","timestamp":1551326521000},"page":"234-240","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of ticagrelor\u2019s cardio-protective effects on patients with ST-segment elevation acute coronary syndrome accompanied with diabetes"],"prefix":"10.1515","volume":"14","author":[{"given":"Dong-Tao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology, Navy General Hospital , Haidian District, 100048 Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-Bao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Baoding First Central Hospital , Baoding , Hebei, 071000 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Navy General Hospital , Haidian District, 100048 Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-hong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Navy General Hospital , Haidian District, 100048 Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Gang","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Navy General Hospital , Haidian District, 100048 Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Navy General Hospital , Haidian District, 100048 Beijing , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Navy General Hospital , No. 6 Fucheng Road, Haidian District , Beijing , People\u2019s Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2019,2,20]]},"reference":[{"key":"2026012107370030803_j_med-2019-0017_ref_001","doi-asserted-by":"crossref","unstructured":"Zhang M, Zhang L, Hu J, Lin J, Wang T, Duan Y, Man W, Feng J, Sun L, Jia H, Li C, Zhang R, Wang H, Sun D: MST1 coordinately regulates autophagy and apoptosis in diabetes cardiomyopathy in mice. Diabetologia. 2016 Nov;59(11):2435-2447","DOI":"10.1007\/s00125-016-4070-9"},{"key":"2026012107370030803_j_med-2019-0017_ref_002","doi-asserted-by":"crossref","unstructured":"Tello-Montoliu A., Tomasello SD, Ueno M, and Angiolillo DJ. Antiplatelet therapy: thrombin receptor antagonists. Br J Clin Pharmacol. 2011 Oct; 72(4): 658-671","DOI":"10.1111\/j.1365-2125.2010.03884.x"},{"key":"2026012107370030803_j_med-2019-0017_ref_003","doi-asserted-by":"crossref","unstructured":"Story RF .Pharmacology and clinical trials of reversibly binding P2Y12 inhibitors. Thromb Haemost. 2011 May; 105 Suppl 1:S75-81","DOI":"10.1160\/THS10-12-0769"},{"key":"2026012107370030803_j_med-2019-0017_ref_004","doi-asserted-by":"crossref","unstructured":"James S, Angiolillo DJ, Cornel JH, Erlinge D, Husted S, Kontny F, Maya J, Nicolau JC, Spinar J, Storey RF, Stevens SR, Wallentin L. Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a sub study from the Platelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J, 2010 31(24): 3006-3016","DOI":"10.1093\/eurheartj\/ehq325"},{"key":"2026012107370030803_j_med-2019-0017_ref_005","doi-asserted-by":"crossref","unstructured":"Hensel KO.Non-ischemic diabetes cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance. Med Hypotheses, 2016 94: 7-10","DOI":"10.1016\/j.mehy.2016.06.002"},{"key":"2026012107370030803_j_med-2019-0017_ref_006","doi-asserted-by":"crossref","unstructured":"Tran JN, Kao TC, Caglar T, Stockl KM, Spertus JA, Lew HC, Solow BK, Chan PS. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year. J Manag Care Spec Pharm ,2016, 22(8): 901-908","DOI":"10.18553\/jmcp.2016.22.8.901"},{"key":"2026012107370030803_j_med-2019-0017_ref_007","doi-asserted-by":"crossref","unstructured":"Wang H, Wang X.Efficacy and safety outcomes of ticagrelor compared with clopidogrel in elderly Chinese patients with acute coronary syndrome. TherClin Risk Manag,2016, 14(12): 1101-1105","DOI":"10.2147\/TCRM.S108965"},{"key":"2026012107370030803_j_med-2019-0017_ref_008","doi-asserted-by":"crossref","unstructured":"Varenhorst C1, Alstr\u00f6m U, Scirica BM, Hogue CW, \u00c5senblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, James S, Cannon CP, Brandrup-Wognsen G, Wallentin L, Held C. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol ,2012, 23;60(17):1623-1630","DOI":"10.1016\/j.jacc.2012.07.021"},{"key":"2026012107370030803_j_med-2019-0017_ref_009","doi-asserted-by":"crossref","unstructured":"Storey RF, Becker RC, Harrington RA, Husted S, James SK, Cools F, Steg PG, Khurmi NS, Emanuelsson H, Lim ST, Cannon CP, Katus HA, Wallentin L. Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy). Am J Cardiol, 2011, 108(11): 1542-1546","DOI":"10.1016\/j.amjcard.2011.07.015"},{"key":"2026012107370030803_j_med-2019-0017_ref_010","doi-asserted-by":"crossref","unstructured":"Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, Ardissino D, Maurer G, Morais J, Nicolau JC, Oto A, Storey RF, James SK, Cannon CP. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study. Circulation,2013, 12;127(6):673-680","DOI":"10.1161\/CIRCULATIONAHA.112.124248"},{"key":"2026012107370030803_j_med-2019-0017_ref_011","doi-asserted-by":"crossref","unstructured":"Anderson JL et al. 2011 ACCF\/AHA Focused Update Incorporated Into the ACC\/AHA 2007 Guidelines for the Management of Patients With Unstable Angina\/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 123(18):e426-579","DOI":"10.1161\/CIR.0b013e318212bb8b"},{"key":"2026012107370030803_j_med-2019-0017_ref_012","doi-asserted-by":"crossref","unstructured":"Panikkath R, Panikkath D, Sanchez-Iglesias S, Araujo-Vilar D, Lado-AbealJ.An Uncommon Association of Familial Partial Lipodystrophy, Dilated Cardiomyopathy, and Conduction System Disease. J Investig Med High Impact Case Rep,2016, 15; 4(3)","DOI":"10.1177\/2324709616658495"},{"key":"2026012107370030803_j_med-2019-0017_ref_013","doi-asserted-by":"crossref","unstructured":"Abdullah CS, Li Z, Wang X, JinZQ.Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetes cardiomyopathy. IntImmunopharmacol, 2016,2(39):251-264","DOI":"10.1016\/j.intimp.2016.07.027"},{"key":"2026012107370030803_j_med-2019-0017_ref_014","doi-asserted-by":"crossref","unstructured":"Sahl\u00e9n A, Varenhorst C, Lagerqvist B, Renlund H, Omerovic E, Erlinge D, Wallentin L, James SK, JernbergT.Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. Eur Heart J. 2016 Nov 21;37(44):3335-3342","DOI":"10.1093\/eurheartj\/ehw284"},{"key":"2026012107370030803_j_med-2019-0017_ref_015","doi-asserted-by":"crossref","unstructured":"Pappas C, Lekakis J, AlexopoulosD.Ticagrelor recommended over clopidogrel in STEMI patients. Expert Rev Cardiovasc Ther ,2016, 14(9):983-985","DOI":"10.1080\/14779072.2016.1204912"},{"key":"2026012107370030803_j_med-2019-0017_ref_016","doi-asserted-by":"crossref","unstructured":"Bernlochner I, Mayer K, Orban M, Morath T, Jaitner J, R\u00f6ssner L, Gross L, Laugwitz KL, Kastrati A, SibbingD.Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study. Platelets. 2016 Dec;27(8):796-804","DOI":"10.1080\/09537104.2016.1190007"},{"key":"2026012107370030803_j_med-2019-0017_ref_017","doi-asserted-by":"crossref","unstructured":"Sardella G, Mancone M, Stio RE, Cavallo E, Di Roma A, Colantonio R, Calcagno. Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus. Circulation.,2017 Aug 8;136(6):602-604","DOI":"10.1161\/CIRCULATIONAHA.117.028745"},{"key":"2026012107370030803_j_med-2019-0017_ref_018","doi-asserted-by":"crossref","unstructured":"Bhatt DL, Bonaca MP, Bansilal S, Angiolillo DJ, Cohen M, Storey RF et al Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54. J Am Coll Cardio,. 2016 Jun 14;67(23):2732-2740","DOI":"10.1016\/j.jacc.2016.03.529"},{"key":"2026012107370030803_j_med-2019-0017_ref_019","doi-asserted-by":"crossref","unstructured":"Alexopoulos D, Vogiatzi C, Stavrou K, Vlassopoulou N, Perperis A., Pentara I, Xanthopoulou I. Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study. Cardiovascular Diabetology Cardiovasc Diabetol. 2015; 14: 68","DOI":"10.1186\/s12933-015-0232-1"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/med\/14\/1\/article-p234.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2019-0017\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2019-0017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:37:10Z","timestamp":1768981030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2019-0017\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,2,20]]},"published-print":{"date-parts":[[2019,2,20]]}},"alternative-id":["10.1515\/med-2019-0017"],"URL":"https:\/\/doi.org\/10.1515\/med-2019-0017","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}